StockData
Trinity Biotech PLC logo

Trinity Biotech PLC (TRIB) stock

TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 1/30
$6.01+0.63 (+11.81%)

Close on Nov 17, 2026Market cap $112.45MP/E –Yield –

Trinity Biotech pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Trinity Biotech's pe ratio was 334.5× on Feb 28, 2023, against 232.8× a year earlier. Over the last 2 years it ranged from 232.8× to 506.3×, with a median of 386.9×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Feb 28, 2023334.5×+20.6
2022Dec 30, 2022313.9×+81.2
2017Feb 28, 2017232.8×−28.3
2016Dec 30, 2016261.1×–

More Trinity Biotech figures

See a number that looks wrong?